indepth look at biologix hair1371 .pdf
Original filename: indepth look at biologix hair1371.pdf
This PDF 1.4 document has been generated by / iTextSharp™ 5.4.1 ©2000-2012 1T3XT BVBA (AGPL-version), and has been sent on pdf-archive.com on 13/07/2013 at 11:48, from IP address 66.248.x.x.
The current document download page has been viewed 569 times.
File size: 9 KB (4 pages).
Privacy: public file
Download original PDF file
indepth look at biologix hair
Something I have actually found out as an investor is that a good item will drive the value of a
business. There are other tangible elements involved, however without the great product the
company will not go anywhere. I enjoy researching companies and trying to find one that I believe
might have the potential for good growth in the future. These business require a product that's
visiting be given market and I believe I have discovered one, in Biologix Hair, Inc (BLGX).
BLGX concentrates on the treatment and prevention of alopecia. Alopecia is the medical term for
baldness, which is a multi-billion dollar sector, $3.5 billion in the United States alone. The
company's item, Biologix Hair Therapy System â¢, takes a various technique to trigger and
therapy then its 2 major rivals on the market today.
Let's take a look at the business's preliminary strategy to baldness, therapy, and competitors.
Biologix Hair, Inc
. Trading at $2.60. Market Cap- $221.4 million
. Preliminary Research and Treatment.
In South America, Dr. Duran and a team of personal clinicians provided "preclinical trial
treatments" to 5,000 clients in a clinically controlled environment over a five-year period. Here are
the estimated results for this preclinical trial of treatment:.
â¢ During those 8 years, the clinicians subjectively approximated that healthy hair growth has
been kept in practically 100 % of individuals whose objective was to prevent the beginning of
Follicle Nutrient Insufficiency Disorder (FNDS) and resulting alopecia.
â¢ Between 80-- 85 % of their male clients and upwards of 90 % of their female clients being
dealt with for FNDS and seeking hair regrowth treatment have actually been able to re-grow their
Biologix Revive hair formula considerably lowers or removes the swelling and encapsulation of
the hair follicles, which permits the nutrients, minerals and vitamins within the formula to restore
those inactive hair follicles.
Unlike the items on the market now, hair rejuvenation therapy is carried out with injection, which I
talk about later on in even more information. It is conducted regular monthly for four to six months
and afterwards bimonthly to strengthen ongoing brand-new growth. Research suggests twice a
year follow-up sees for maintenance.
Why injections instead of topical? Dr. Durand's team identified that topical therapies have an
extremely shallow penetration level in between.3 and.4 MM maximum. But the issue lies at the
root inside the hair follicle, which is 3 to 4 MM deep. For this reason they decided to use injections
into the follicle root layer in their preclinical trials.
Dr. Duran and his team technique their research from the property that follicles that were not
growing exist in a "inactive state." Research was originally done to determine the biological
processes included and corresponding impacts upon follicles that would establish a possible
avoidance and renovation procedure.
As an investor, it is a great idea to understand how this business's hair growth therapy program
works and to understand its vision for the future.
Cycle of Hair Grow.
â¢ Phase I-- Anagen (I, II and III): active growth phase during which new hair shaft forms, pushes
out old shaft and emerges from follicle aperture on scalp.
â¢ Phase II-- Catagen: transitional stage during which hair follicle reduces, dermal papilla escape
from hair shaft and inactivates.
â¢ Phase III-- Telogen: called a resting phase, hairs are easily lost at this point.
â¢ Stage IV-- Exogen: losing of the old hair. After a quick time frame, the hair follicle go back to
Anagen I and the cycle is duplicated.
Its present research and development stage with a leading college needs to take about 12
months to complete. Hair follicles do not grow in unison and might be in different stages of
development, and this is the method hair regenerates itself. In their research, Dr. Duran figures
out that it's the third phase or the "telogen" phase that triggers "Follicle Nutrient Deficiency
Syndrome." A collagen band types from the base of the follicle hence limiting or significantly
weakening hair growth.
By injecting into the hair root follicle, the matching nutrients help "revive" the hair follicle and deals
with eliminating the "collagen band". As a result, the inactive hair follicle returns to life and begins
expanding usually again.
Dealing with FDA Approval.
The company is focused on acquiring FDA approval for its baldness avoidance and regrowth
therapy. Presently it is investing about YEAR completing its R&D program selecting the Beijing
Institute of Innovation, which is the last step before formal clinical trials and the start of the FDA
While this is taking place the management group is figured out to be prepared to position itself to
take advantage of high-margin sales from the Biologix Hair Treatment System, if and when the
FDA and various other major markets offer last approval. The variety of qualified medical facilities
that have actually signed contractual bookings to become licensed for the treatment system is
now up to 276. The approximated variety of existing patients would want either the hair loss
avoidance or regrowth treatment and are candidates for the Biologix Hair Therapy System has
climbed to over 1,300,000 clients.
Biologix Hair Science Ltd. â¢, is going to open a business possessed and run Biologix Hair
Therapy Center â¢ in Cartagena, Colombia prior to the end of October.
The center will offer its patent pending hair thinning therapy for the first time, which will allow the
company to begin creating profits. The therapy facility will also double as a training center for
licensed clinicians who have contract with the business to offer these types of hair centers. This
will work as a prototype for future centers that will not be run by the company but by the clinicians
Dr. Diego Castresana, Vice President of Research and Development for Biologix Hair Science
Ltd. had this to state about the benefit of the Center's place, "Being based right here allows me to
personally oversee center operations to make sure the highest requirements possible are
continually complied with. And with direct air travels from major around the world flight terminals,
it is also hassle-free for physicians to attend and get professional training.".
From an investor's standpoint is essential to know that Biologix has competitors from 2 famous
global companies you might be familiar with, Merck and Johnson & Johnson. Between them lies a
$460 million sector.
Merck $MRK has a hair thinning product called Propecia that produces about $400 million
annually for the business. The product works by shutting out the development of specific sorts of
male pattern hair loss. It lowers the development of DHT in the scalp that additional inhibits the
shrinking of the afflicted hair follicles.
Does it work?
Would like to know if Propecia really worked, a research was carried out for men who lost hair on
the top of their head. Men who took the Propecia expanded brand-new hair while those on the
placebo didn't. After about a year new hair growth stopped and they slowly started to lose it once
again but the loss rate was much lower than those who had the placebo. Right here are the longterm stats after 5 years:.
â¢ 48 % of men had actually enhanced hair growth.
â¢ 42 % had no change (the baldness had actually stopped).
â¢ 10 % had actually lost hair.
â¢ On the placebo, 75 % had lost hair after five years.
â¢ When guys stopped taking Propecia, the beneficial results for hair loss wore off over one year.
Its active ingredient is finasteride.
Some of the problems for guys with Propecia is the sexual negative side effects caused by
finasteride. In fact, 1,524 males were treated with the active component and below are the
â¢ 5.1 % of patients experienced impotence (impotence).
â¢ 6.4 % developed lowered sex drive (libido).
â¢ 3.7 % had actually a minimized quantity of semen.
â¢ 0.8 % had trouble ejaculating.
â¢ An additional side effect was pain in the testicles.
Johnson and Johnson $JNJ is an additional competitor with a hair loss medicine called Rogaine
that has a market share of just over $60 million a year.
When put on the head twice a day is thought to revitalize shrunken hair follicles by increasing
blood flow to the locations near the balding area. This enhances the growing stage of the hair
thus promoting hair growth. The concept is to "slow down the rate where they pass away"
permitting hair to remain to grow as long as the therapy continues.
A 16 week study exposed that 85 % of clients experienced hair growth and in females a 48 week
research revealed that 60 % of females also experienced hair development. The active ingredient,
minoxidil, expands the blood vessels around the scalp rise blood flow to the hair root. With added
nutrition, the follicles become revitalized and the cells begin to multiply once again as brand-new
hair expands. Like Propecia, the outcomes of using Rogaine work only as long as the product is
being made use of. According to the Mayo Clinic, after stopping the product the hair will return to
its initial growth state.
Can Biologix Compete?
This is a question every investor wants to know. I believe the secret to answering this question is
resolving the foundational hypothesis of research into baldness. While Rogaine and Propecia
effort to treat "dead or dying" hair follicles, the Biologix Hair Therapy treatment searched and
created a formula based upon a "inactive" hair follicle-- not a dead one.
Instead of hair follicles passing away, they are inflamed and lack the typical nutrients that the
body delivers to healthy hair follicles. Good sense would inform anyone that a malnourished hair
follicle would be incapable to do its regular feature.
The brand-new technique to treating hair loss and avoidance had superior pre-clinical trial results.
Management has built a strong worldwide network to get ready to market the item. With
preparation for FDA clinical trials taking place in the United States and work on getting approval in
Western Europe, the company will start dispersing its item in 2014.
The product moves the business. Biologix is at that "pre-distribution stage" that could enhance the
value of the company in the coming years. I believe this business has a strong product and has a
likelihood of catching a good part of global market share in the years to come. I would motivate
investors to do your own research and delve deeper into this company as a possible investment.
As with all investments, it is very important to know that this company is getting in a trial stage
and does not have regular earnings. Before purchasing any business please remember to
ascertain the threat included.
For more information: relevant webpage